StockWatch
·

Boston Bio Systems Ltd Q3 FY26 Results

BOSTONQ3 FY26 Results
Filing
MetricValue ( Cr)vs Q2 FY26
Revenue0.0675.9%
Total Income0.0675.9%
Expenditure0.0762.0%
PBT-0.01126.6%
Net Profit-0.01135.5%
OPM
NPM-23.73%39.83pp
EPS-0.02133.3%
View full financials

Informational and educational content only. Not investment advice.